Imagion Biosystems Limited (IBXXF PINK) stock market data APIs
$0.035
0(0%)
as of January 13, 2025
Imagion Biosystems Limited Financial Data Overview
Price chart is built with
Anychart
Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers, as well as in preclinical stage to treat prostate, ovarian, brain, and pancreatic cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to detect cancer. The company has a collaborative research program with Patrys Limited and The University of Sydney. Imagion Biosystems Limited was incorporated in 2016 and is based in South Melbourne, Australia.
Prev. Close
0.035
Open
0.035
Volume
0
High
0.035
Low
0.035
52 wk Range
0.035-0.256
Market Cap
7 047 K
Shares Outstanding
201 M
Revenue
5 916 K
EPS
-0.0005
Beta
1.978
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Imagion Biosystems Limited data using free add-ons & libraries
Get Imagion Biosystems Limited Fundamental Data
Imagion Biosystems Limited Fundamental data includes:
- Net Revenue: 5 916 K
- EBITDA: -5 483 904
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Imagion Biosystems Limited News
New
Imagion Biosystems' (ASX:IBX) investors will be pleased with their solid 125% return over the last three years
Imagion Biosystems Limited (ASX:IBX) shareholders have seen the share price descend 13% over the month. But in three years the returns have been great. In three years the stock price has launched 113%...
We're Hopeful That Imagion Biosystems (ASX:IBX) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after lis...
Investors Who Bought Imagion Biosystems (ASX:IBX) Shares A Year Ago Are Now Up 22%
Imagion Biosystems Limited (ASX:IBX) shareholders have seen the share price descend 19% over the month. But at least the stock is up over the last year. However, its return of 22% does fall short of t...
We're Not Very Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Imagion Biosystems (ASX:IBX) shareholders have done very well over the last year, with the share price...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
